Skills: The global gold rush

How can stakeholders come together to address cell and gene therapy’s global talent gap? Do we have the right skills and capabilities in place to identify and develop the next generation of ATMPs?


JAMES STRACHAN | Editor | The Cell + Gene Curator


SVEN KILI | Chief Executive Officer | Antion Biosciences
TONY KHOURY | Executive Vice President | Project Farma
BRUCE LEVINE | Founding Director | Clinical Cell and Vaccine Production Facility
TAMAS MASZTIS | Senior Director | Cell Therapy Supply Chain for Europe, Kite, a Gilead Company
CLAIRE THOMPSON | Chief Executive Officer | Agility Life Sciences